scholarly journals MRI cT1-2 rectal cancer staging accuracy: a population-based study

2020 ◽  
Author(s):  
R. Detering ◽  
S. E. van Oostendorp ◽  
V. M. Meyer ◽  
S. van Dieren ◽  
A. C. R. K. Bos ◽  
...  
Keyword(s):  
Rectal Cancer ◽  
Cancer Staging ◽  
Population Based ◽  
Population Based Study ◽  
Rectal Cancer Staging ◽  
Staging Accuracy

scholarly journals Su1288 SIZE MATTERS: TUMOR SIZE IMPACTS ENDOSONOGRAPHIC RECTAL CANCER STAGING ACCURACY

2020 ◽  
Vol 91 (6) ◽  
pp. AB314
Author(s):  
Benjamin D. Renelus ◽  
Daniel S. Jamorabo ◽  
Ezana Bekele ◽  
Pragnan Kancharla ◽  
Hashroop Gurm ◽  
...  
Keyword(s):  
Rectal Cancer ◽  
Tumor Size ◽  
Cancer Staging ◽  
Rectal Cancer Staging ◽  
Staging Accuracy

Use of Primary Radiotherapy for Rectal Cancer in the Netherlands between 1997 and 2008: A Population-based Study

2012 ◽  
Vol 24 (1) ◽  
pp. e1-e8 ◽  
Author(s):  
J.J. Jobsen ◽  
M.J. Aarts ◽  
S. Siesling ◽  
J. Klaase ◽  
W.J. Louwman ◽  
...  
Keyword(s):  
Rectal Cancer ◽  
The Netherlands ◽  
Population Based ◽  
Population Based Study ◽  
Primary Radiotherapy

scholarly journals Accuracy of High-Resolution MRI with Lumen Distention in Rectal Cancer Staging and Circumferential Margin Involvement Prediction

2014 ◽  
Vol 15 (1) ◽  
pp. 37 ◽  
Author(s):  
Elsa Iannicelli ◽  
Sara Di Renzo ◽  
Mario Ferri ◽  
Emanuela Pilozzi ◽  
Marco Di Girolamo ◽  
...  
Keyword(s):  
Rectal Cancer ◽  
High Resolution ◽  
Cancer Staging ◽  
Circumferential Margin ◽  
Margin Involvement ◽  
Rectal Cancer Staging ◽  
High Resolution Mri

MRI for rectal cancer: Staging, mrCRM, EMVI, lymph node staging and post-treatment response

2021 ◽  
Author(s):  
David D.B. Bates ◽  
Maria El Homsi ◽  
Kevin Chang ◽  
Neeraj Lalwani ◽  
Natally Horvat ◽  
...  
Keyword(s):  
Rectal Cancer ◽  
Lymph Node ◽  
Treatment Response ◽  
Cancer Staging ◽  
Post Treatment ◽  
Lymph Node Staging ◽  
Rectal Cancer Staging

scholarly journals Conditional Survival and Cure of Patients With Colon or Rectal Cancer: A Population-Based Study

2020 ◽  
Vol 18 (9) ◽  
pp. 1230-1237 ◽  
Author(s):  
Seyed M. Qaderi ◽  
Paul W. Dickman ◽  
Johannes H.W. de Wilt ◽  
Rob H.A. Verhoeven
Keyword(s):  
Rectal Cancer ◽  
Colon Cancer ◽  
Population Based ◽  
Stage I ◽  
Stage Iii ◽  
Disease Stage ◽  
Conditional Survival ◽  
Population Based Study ◽  
Pathologic Stage ◽  
Number Of Patients

Background: The increasing number of colorectal cancer (CRC) survivors need survival estimates that account for the time already survived. The aim of this population-based study was to determine conditional survival, cure proportions, and time-to-cure (TTC) of patients with colon or rectal cancer. Materials and Methods: All patients with pathologic stage I–III CRC treated with endoscopy or surgery, diagnosed and registered in the Netherlands Cancer Registry between 1995 and 2016, and aged 18 to 99 years were included. Conditional survival was calculated for those diagnosed before and after 2007. Cure proportions were calculated using flexible parametric models. Results: A total of 175,384 patients with pathologic stage I (25%), II (38%), or III disease (37%) were included. Conditional 5-year survival of patients with stage I, II, and III colon cancer having survived 5 years was 98%, 94%, and 92%, respectively. For patients with stage I–III rectal cancer, this was 96%, 89%, and 85%, respectively. Statistical cure in patients with colon cancer was reached directly after diagnosis (stage I) to 6 years (stage III) after diagnosis depending on age, sex, and disease stage. Patients with rectal cancer reached cure 0.5 years after diagnosis (stage I) to 9 years after diagnosis (stage III). In 1995, approximately 42% to 46% of patients with stage III colon or rectal cancer, respectively, were considered cured, whereas in 2016 this percentage increased to 73% to 78%, respectively. Conclusions: The number of patients with CRC reaching cure has increased substantially over the years. This study’s results provide valuable insights into trends of CRC patient survival and are important for patients, clinicians, and policymakers.

Sign in / Sign up

Export Citation Format

Share Document